Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9

Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells

(2008) Shijun Kang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia

(2008) D. Jankovic et al.   BLOOD

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

(2008) M. Bernard et al.   CURRENT PHARMACEUTICAL DESIGN

Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies

(2008) Yulia Nefedova et al.   DRUG RESISTANCE UPDATES

A role for the transcription factor HEY1 in glioblastoma

(2008) Esther Hulleman et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies

(2008) Pawel Robak et al.   LEUKEMIA & LYMPHOMA

Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor

(2008) K Hirose et al.   ONCOGENE